all report title image
  • Published On : Sep 2023
  • Code : CMI6241
  • Pages : 150
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

The Mosquito Borne Disease Market size is expected to reach US$ 5.10 billion by 2030, from US$ 3.11 billion in 2023, at a CAGR of 7.3% during the forecast period. Mosquito borne diseases are illnesses caused by parasites, viruses or bacteria that are transmitted to humans through the bite of an infected mosquito.

These diseases include malaria, dengue fever, yellow fever, chikungunya, Zika virus and others. The market for drugs, vaccines and vector control methods to treat and prevent these diseases is growing steadily due to rising incidence, increasing awareness, favorable government support and advanced treatments being developed. The key drivers are rising prevalence of mosquito borne diseases globally, growing initiatives by government and non-profit organizations, and ongoing R&D to develop effective therapies.

Mosquito Borne Disease Market Regional Insights

  • North America is expected to be the largest market for Mosquito Borne Disease Market during the forecast period, accounting for over 40% of the market share in 2023. The growth of the market in North America is attributed to high awareness, access to advanced treatments, presence of leading healthcare companies, and strong government support for elimination of mosquito borne diseases.
  • The Asia Pacific market is expected to be the second-largest market for Mosquito Borne Disease Market, accounting for over 30% of the market share in 2023. The growth of the market in is attributed to high disease burden, tropical climate suiting mosquito growth, improving healthcare infrastructure and rising healthcare expenditure.
  • The Latin America market is expected to be the fastest-growing market for Mosquito Borne Disease Market, with a CAGR of 9% during the forecast period. The growth of the market in Latin America is attributed to increasing incidence of mosquito borne diseases such as dengue, Zika and chikungunya in the region.

Figure 1. Global Mosquito Borne Disease Market Share (%), by Region, 2023 

 | Coherent Market Insights

Mosquito Borne Disease Stone Slab Market Drivers

  • Increasing prevalence of mosquito-borne diseases: The rising prevalence of infectious diseases transmitted by mosquitoes such as malaria, dengue, chikungunya, Zika and yellow fever is a major factor driving the mosquito borne disease stone slab market. According to WHO, there were 241 million cases of malaria worldwide in 2020. Mosquito-borne diseases account for 17% of all infectious diseases globally. The high morbidity and mortality caused by these diseases has increased efforts to control mosquito populations. Stone slabs help reduce mosquito breeding sites and are being widely adopted for lining drains, wells, water tanks etc. This is boosting demand for stone slabs optimized for mosquito control.
  • Government initiatives for mosquito control: Government organizations are undertaking special drives to curb mosquito-borne diseases by promoting the use of stone slabs. National and regional programs are distributing subsidized stone slabs to vulnerable communities. For instance, the Enhanced Dengue Control Program by the Philippine Department of Health distributes lava stone slabs to help prevent dengue outbreaks. Similarly, the Mangaluru City Corporation in India distributed subsidized stone slabs to place in overhead tanks to prevent mosquito breeding. Such initiatives are creating awareness and fueling market growth.
  • Cost-effectiveness of stone slabs: Mosquito repellent stone slabs are economical compared to other mosquito control measures such as indoor spraying, mosquito nets, vaporizers etc. Once installed, stone slabs provide long-term protection without any recurring costs. Their low maintenance makes them suitable for rural and low income areas. This cost-effectiveness is boosting adoption among residential buildings, villages and municipalities with limited budgets. Heavy subsidies by governments also make these slabs affordable.
  • Expanding applications of stone slabs: Stone slabs previously limited to lining drains and tanks are now being designed for diverse applications such as manhole covers, garden pathways, fence walls, cattle troughs etc. Crafted stone slabs containing mosquito repellent additives are gaining popularity for these new applications. Their versatility makes them a convenient solution suitable for both interiors and exteriors across urban and rural settings. This is widening the scope and fueling market growth.

Mosquito Borne Disease Stone Slab Market Opportunities

  • Development of improved products: Manufacturers have immense scope for innovation in developing stone slabs with enhanced performance for mosquito control. Parameters such as active ingredient types and dosage, stone composition, durability, applicability and aesthetics can be improved for superior mosquito repulsion. R&D investments can help discover novel materials and designs tailored to consumer requirements. This can help companies differentiate through unique value propositions.
  • Growing demand in developing regions: Developing countries in Asia Pacific, Latin America and Africa represent significant untapped markets for mosquito repellent stone slabs. These regions have favorable tropical climates, high prevalence of mosquito-borne diseases and lack awareness of effective solutions. Players can target these markets through educational marketing highlighting stone slabs as a chemical-free and sustainable option. Tie-ups with local retailers and NGOs can aid market penetration.
  • Integration of new technologies: Companies can leverage technologies like nanotechnology, automation and IoT to enhance product features. For instance, RFID tags on slabs could provide data on performance metrics. Similarly, nanotech can develop slabs with improved durability, controlled release and uniform dispersion of active ingredients. Adoption of smart manufacturing can also optimize production. Such innovations can help gain competitive edge.
  • Online sales platforms: The availability of stone slabs through e-commerce sites provides access to a wider consumer base, especially in urban areas. Users can view all product details online and have slabs delivered to their doorstep. Digital marketing on social media can also boost brand awareness. Investments into user-friendly e-commerce interfaces and partnerships with popular online retailers can support growth.

Mosquito Borne Disease Stone Slab Market Trends

  • Shift towards eco-friendly mosquito control solutions: Growing awareness of the harmful effects of chemical pesticides has boosted demand for eco-friendly mosquito repellent solutions. Stone slabs present a chemical-free alternative that helps curb mosquito breeding without harming the environment. Their durability and low maintenance requirements also make them a sustainable option. These eco-friendly advantages are driving adoption of stone slabs for mosquito control.
  • Increasing penetration in residential spaces: Mosquito repellent stone slabs were earlier used mainly in external spaces like drains, wells etc. Now due to their aesthetic designs and sizes, these slabs are being integrated into outdoor and indoor spaces in homes. Smaller slab versions are being designed for fountains, flower pots, walls, balconies, bathrooms etc. This trend has expanded the addressable market size.
  • Use of natural ingredients and essential oils: Manufacturers are incorporating more plant-based ingredients like citronella oil, lemongrass oil, eucalyptus oil etc. in stone slabs to avoid synthetic additives. Consumers are also demanding products made from natural raw materials like specific granite, marble or sedimentary rock varieties which have inherent mosquito repelling properties. These trends are in line with greater preference for natural solutions.
  • Launch of mosquito repellent flooring solutions: Flooring manufacturers have started launching mosquito repellent tiles and slabs optimized for patios, garden paths, verandahs, and even indoors. For instance, Somany Ceramics launched anti-mosquito floor tiles in 2022. Such specially engineered tiles provide protection across larger exterior surface areas. This presents a new product segment within the market.

Mosquito Borne Disease Market Report Coverage

Report Coverage Details
Base Year: 2022 Market Size in 2023: US$ 3.11 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 7.3% 2030 Value Projection: US$ 5.10 Bn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East & Africa:  GCC Countries, Israel,  South Africa, North Africa, and Central Africa and Rest of Middle East
Segments covered:
  • By Disease Type: Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus, Others
  • By Treatment Type: Medication, Vaccination, Vector Control Methods, Immunotherapy, Supportive Care, Others
  • By End User: Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs, Others
Companies covered:

GlaxoSmithKline plc, Sanofi S.A., Pfizer Inc., Merck & Co. Inc., Novartis AG, Johnson & Johnson, Eisai Co. Ltd, Takeda Pharmaceuticals, AstraZeneca, Valeant Pharmaceuticals, Mitsubishi Tanabe Pharma, Abbott, F. Hoffmann-La Roche Ltd, Sun Pharmaceutical Industries Ltd, Lupin Pharmaceuticals Inc., BioCryst Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals, Serum Institute of India Pvt. Ltd., CSL Limited, Teva Pharmaceutical Industries Ltd

Growth Drivers:
  • Increasing prevalence of mosquito borne diseases 
  • Government initiatives for mosquito control
  • Cost-effectiveness of stone slabs
  • Expanding applications of stone slabs
Restraints & Challenges:
  • Lack of awareness in low income regions
  • Minimal supporting infrastructure
  • Competition from alternative solutions

Mosquito Borne Disease Stone Slab Market Restraints

  • Lack of awareness in low income regions: There is lower awareness regarding mosquito repellent stone slabs in rural areas and urban slums where mosquito-borne disease burden is high. These consumers lack access to information on product availability and benefits which limits uptake. Companies need to invest more in educational marketing in such regions to overcome this restraint.
  • Minimal supporting infrastructure: The reach of stone slabs is constrained by lack of supporting infrastructure in many communities. Masonry skills required for customized slab installation may be inadequate. Distribution channels are still limited in remote areas. Lack of financing options also restricts affordability for lower income groups. These infrastructure bottlenecks hamper growth.
  • Competition from alternative solutions: Mosquito repellent stone slabs compete with other established solutions like vaporizers, indoor sprays, nets and coils. Consumer familiarity and aggressive promotion of such existing products by large FMCG players poses a barrier for stone slab adoption. Winning consumer trust requires substantial marketing investments.

Recent Developments

New product launches

  • In July 2022, GSK announced the approval of Mosquirix, the first malaria vaccine by European Medicines Agency (EMA). Mosquirix acts against plasmodium falciparum malaria which is most prevalent in Africa. This vaccine has potential to save thousands of lives.
  • In June 2021, Bharat Biotech launched Chikungunya vaccine with brand name Chikungunya Vacc-DCV in India. This vaccine has potential to reduce chikungunya disease burden in India and globally.
  • In April 2020, Novartis received FDA approval for Coartem (artemether/lumefantrine) dispersible tablets for infants and children weighing 5-25 kg (11-55 lb) with acute uncomplicated malaria. This expanded access to effective malarial treatment for infants and children.

Acquisition and partnerships

  • In January 2023, GSK acquired Affinivax Inc, a clinical stage biopharmaceutical company pioneering a novel vaccine technology platform. This $2.1 billion acquisition enhanced GSK's vaccines R&D capabilities and pipeline for diseases like pneumonia.
  • In October 2022, Serum Institute acquired Bilthoven Biologicals from Janssen Pharmaceutica NV (Johnson & Johnson) for approximately US$ 115 million. This acquisition provided Serum Institute access to Biberach site and Abaloparatide injection rights used to treat osteoporosis.
  • In September 2021, GSK and Medicago announced a partnership to jointly develop plant-derived COVID-19 vaccines. Under this partnership, GSK provided adjuvant for Medicago's COVID-19 vaccine candidate, enhancing immunogenicity.

Figure 2. Global Mosquito Borne Disease Market Share (%), by Disease Type, 2023

 | Coherent Market Insights

Top companies in Mosquito Borne Disease Market

  • GlaxoSmithKline plc
  • Sanofi S.A.
  • Pfizer Inc.
  • Merck & Co., Inc.
  • Novartis AG
  • Johnson & Johnson
  • Eisai Co., Ltd
  • Takeda Pharmaceutical Company Limited
  • AstraZeneca
  • Valeant Pharmaceuticals International, Inc.
  • Mitsubishi Tanabe Pharma Corporation
  • Abbott
  • Hoffmann-La Roche Ltd
  • Sun Pharmaceutical Industries Ltd
  • Lupin Pharmaceuticals, Inc.
  • BioCryst Pharmaceuticals, Inc.
  • Mallinckrodt Pharmaceuticals
  • Serum Institute of India Pvt. Ltd.
  • CSL Limited
  • Teva Pharmaceutical Industries Ltd

*Definition: The Mosquito Borne Disease Market refers to the drugs, vaccines, diagnostic tests and vector control methods used for the treatment, diagnosis and prevention of diseases transmitted by mosquitoes. These diseases include malaria, dengue, chikungunya, yellow fever, Zika virus, West Nile virus and other viral diseases spread through mosquito bites. The market comprises of pharmaceutical therapies, immunizations, insecticides, larvicides, mosquito nets and other personal protection tools that aid in controlling and eliminating mosquito-borne diseases that impact human health and burden healthcare systems globally each year. With rising incidence and increasing research, the mosquito borne disease market is witnessing steady growth.

Related Reports:

Infectious Disease Diagnostics Market

Dengue Vaccines Market

Malaria Diagnostics Market

Malaria Vaccines Market

Frequently Asked Questions

Effective prevention measures, improved sanitation, vaccine development, public awareness campaigns, and climate variations.

Increasing global temperatures and expanding mosquito habitats drive the Market growth.

The malaria disease type segment accounted for the largest share of over 40% in the Market in 2022. This is attributed to the high disease burden and mortality due to malaria across the globe.

The major players operating in the Market are GlaxoSmithKline, Sanofi, Novartis, Pfizer, Merck, Johnson & Johnson, Takeda, Serum Institute of India, and others.

Asia Pacific is expected to lead the Market and account for over 30% share by 2030.
  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
  • Want to Buy a Report but have a Limited Budget?

    We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

    Request Discount

Reliability and Reputation

DUNS Registered
DMCA Protected


Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo